Literature DB >> 16098550

Immunodetection of the signal transducer and activator of transcription-3 in canine haemangioma and haemangiosarcoma.

Claudio Petterino1, Enrica Rossetti, Michele Drigo.   

Abstract

The aim of this study was to examine the expression of signal transducer and activator of transcription 3 (STAT3) in canine haemangiomas and haemangiosarcomas. STAT3 protein was demonstrated in both the cytoplasm and nuclei of labelled cells. The expression of STAT3 was observed in 87.50% (35/40) of both haemangiomas and haemangiosarcomas and 72.22% (13/18) of haemangiomas and 100% (22/22) haemangiosarcomas. The percentage of positive cells in haemangiomas and haemangiosarcomas was statistically significant difference (P<0.0001). These preliminary results indicate that STAT3 is overexpressed in malignant tumours.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098550     DOI: 10.1016/j.rvsc.2005.05.009

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  4 in total

1.  Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours.

Authors:  C Petterino; G Podestà; A Ratto; M Drigo; C Pellegrino
Journal:  Vet Res Commun       Date:  2006-12-20       Impact factor: 2.459

2.  Equine renal hemangiosarcoma: clinical presentation, pathologic features, and pSTAT3 expression.

Authors:  Katherine Hughes; Victoria H L Scott; Maximilian Blanck; Timothy P Barnett; Jannie Spanner Kristiansen; Alastair K Foote
Journal:  J Vet Diagn Invest       Date:  2017-12-03       Impact factor: 1.279

3.  Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study.

Authors:  Laura E Barrett; Heather L Gardner; Lisa G Barber; Abbey Sadowski; Cheryl A London
Journal:  BMC Vet Res       Date:  2019-08-13       Impact factor: 2.741

4.  STAT3 Expression and Activity are Up-Regulated in Diffuse Large B Cell Lymphoma of Dogs.

Authors:  A L F V Assumpção; P C Jark; C C Hong; Z Lu; H M Ruetten; C M Heaton; M E Pinkerton; X Pan
Journal:  J Vet Intern Med       Date:  2017-11-09       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.